The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of Hospitalization due to Vaso-Occlusive Crises

被引:18
|
作者
Ballas, Samir K. [1 ]
机构
[1] Thomas Jefferson Univ, Dept Med, Sidney Kimmel Med Coll, Cardeza Fdn Hematol Res, 1020 Locust St, Philadelphia, PA 19107 USA
关键词
cannabinoid; cannabis; sickle cell disease; VOC;
D O I
10.1089/can.2017.0011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: The objective of this study was to determine if patients with sickle cell disease using cannabis had decreased frequency of acute vaso-occlusive crises (VOCs) that required hospitalization. Method: This was a retrospective study in which 270 urine drug screen tests were done on 72 patients: 40 males and 32 females. Results: Cannabinoids were found in 144 urine tests from 37 patients and were negative in 126 tests from 35 patients. Males who used cannabis were significantly younger (p0.001) than males who did not. Patients who tested positive used benzodiazepines, cocaine, and phencyclidine significantly more often than patients who tested negative. There was no significant difference in the amounts of opioids consumed by users and nonusers of cannabis. The cannabis cohort was seen in the clinic significantly (p0.05) less often than controls, but hospital admissions were significantly greater in the cannabis group than controls (p0.05). Conclusion: These data show an unexpected negative effect of cannabis on the frequency of VOCs. This may be due to the effect of cannabis on the brain and/or the severity of the disease in the cannabis users. More controlled studies are needed to clarify these findings.
引用
收藏
页码:197 / 201
页数:5
相关论文
共 50 条
  • [21] Long-term outcomes in patients with sickle cell disease and frequent vaso-occlusive crises
    Prasad, R
    Hasan, S
    Castro, O
    Perlin, E
    Kim, K
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (03): : 107 - 109
  • [22] Haemoglobin Ottawa, sickle cell trait and vaso-occlusive crises
    Bobillier, Cecile
    Derclaye, Isabelle
    Ferrant, Augustin
    Maisin, Diane
    EJHAEM, 2024, 5 (01): : 33 - 38
  • [23] Ketamine for Sickle Cell Vaso-Occlusive Crises: A Systematic Review
    Alshahrani, Mohammed S.
    Alghamdi, Mohannad A.
    SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES, 2021, 9 (01) : 3 - +
  • [24] Hyperbaric oxygen therapy for vaso-occlusive crises in nine patients with sickle-cell disease
    Stirnemann, Jerome
    Letellier, Edouard
    Aras, Nazmiye
    Borne, Marc
    Brinquin, Louis
    Fain, Olivier
    DIVING AND HYPERBARIC MEDICINE, 2012, 42 (02) : 82 - 84
  • [25] BARRIERS TO IMPROVING ANALGESIA FOR VASO-OCCLUSIVE PAIN CRISES IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
    Allewelt, Heather
    Saricicek, Jessica
    Patel, Sachit
    Rothman, Jennifer
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 40 - 40
  • [26] Frequent Vaso-occlusive Crises Alter Brain Network Connectivity in Patients with Sickle Cell Disease
    Ichesco, Eric
    Pucka, Andrew Q.
    Harris, Richard E.
    Wang, Ying
    JOURNAL OF PAIN, 2024, 25 (04): : 47 - 47
  • [27] PROPHYLAXIS OF SICKLE-CELL VASO-OCCLUSIVE CRISES WITH PIRACETAM
    SONNET, J
    GINI, EK
    CORNU, G
    ANNALES DE LA SOCIETE BELGE DE MEDECINE TROPICALE, 1985, 65 (01): : 77 - 84
  • [28] Tramadol use in pediatric sickle cell disease patients with vaso-occlusive crisis
    Mary P Borgerding
    Randall K Absher
    Tsz-Yin So
    World Journal of Clinical Pediatrics, 2013, (04) : 65 - 69
  • [29] THE RELATIONSHIP BETWEEN VASO-OCCLUSIVE CRISES AND WORK PRODUCTIVITY IMPAIRMENT IN PATIENTS WITH SICKLE CELL DISEASE
    Rizio, A.
    Bhor, M.
    Lin, X.
    White, M. K.
    Paulose, J.
    Nandal, S.
    Halloway, R., I
    Bronte-Hall, L.
    VALUE IN HEALTH, 2019, 22 : S345 - S345
  • [30] Elimination of vaso-occlusive crises after exagamglogene autotemcel in patients with severe Sickle Cell Disease
    Meisel, R.
    Frangoul, H.
    Locatelli, F.
    Sharma, A.
    Bhatia, M.
    Molinari, L.
    Wall, D.
    Liem, R.
    Telfer, P.
    Shah, A.
    Cavazzana, M.
    Corbacioglu, S.
    Rondelli, D.
    Dedeken, L.
    Lobitz, S.
    de Montalembert, M.
    Steinberg, M.
    Walters, M.
    Imren, S.
    Shi, D.
    Bower, L.
    Simard, C.
    Zhang, L.
    Morrow, P. K.
    Hobbs, B.
    Grupp, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 99 - 100